feed,title,long_url,short_url
Benzinga,Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track,https://benzinga.com/general/biotech/23/06/33018677/second-most-prevalent-bacterial-sexually-transmitted-infection-gsks-gonorrhea-vaccine-secures-fda,https://da.gd/Qo9d7a
Benzinga,Sanofi's Amlitelimab Hits Primary Goal In Mid-Stage Atopic Dermatitis Study,https://benzinga.com/general/biotech/23/06/33018311/sanofis-amlitelimab-hits-primary-goal-in-mid-stage-atopic-dermatitis-study,https://da.gd/sv1bgi
